COVID–19 Vaccine Accountability Act

Bill 117 hr 6282, also known as the COVID–19 Vaccine Accountability Act, is a piece of legislation introduced in the US Congress. The main purpose of this bill is to establish a system of accountability and transparency for the development and distribution of COVID-19 vaccines.

The bill requires the Secretary of Health and Human Services to submit a report to Congress detailing the progress of COVID-19 vaccine development, including information on clinical trials, manufacturing, and distribution plans. This report must be updated regularly to ensure that Congress and the public are kept informed of the status of vaccine development.

Additionally, the bill requires the Secretary to establish a public database to track the distribution of COVID-19 vaccines, including information on the number of doses distributed, the locations where vaccines are being administered, and any adverse reactions reported. This database will help ensure that vaccines are being distributed equitably and that any potential safety concerns are addressed promptly. Overall, the COVID–19 Vaccine Accountability Act aims to increase transparency and accountability in the development and distribution of COVID-19 vaccines, helping to build public trust in the vaccination process and ensure that vaccines are distributed fairly and safely.